Page last updated: 2024-11-10

hcv 371

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3013096
CHEMBL ID390282
SCHEMBL ID3487701
MeSH IDM0479491

Synonyms (14)

Synonym
2-[(1r)-5-cyano-8-methyl-1-propyl-4,9-dihydro-3h-pyrano[3,4-b]indol-1-yl]acetic acid
hcv-371
(5-cyano-8-methyl-1-propyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
pyrano[3,4-b]indole-1-acetic acid, 5-cyano-1,3,4,9-tetrahydro-8-methyl-1-propyl-, (1r)-
CHEMBL390282
SCHEMBL3487701
unii-nbnlikbz5n
463941-20-0
pyrano(3,4-b)indole-1-acetic acid, 5-cyano-1,3,4,9-tetrahydro-8-methyl-1-propyl-, (1r)-
NBNLIKBZ5N ,
675184-27-7
(r)-2-(5-cyano-8-methyl-1-propyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
PD160164
AKOS040752000

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" These mt-QSARs offer also a good opportunity to construct drug-drug Complex Networks (CNs) that can be used to explore large and complex drug-viral species databases."( Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (25)

Assay IDTitleYearJournalArticle
AID479452Inhibition of HCV BK NS5B polymerase2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
AID479457Apparent permeability from apical to basolateral side of human Caco-2 cells2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
AID597868Inhibition of HCV BB7 NS5B polymerase after 15 mins2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
AID282092Cytotoxicity against Huh7 cells by MTS assay2004Journal of medicinal chemistry, Dec-16, Volume: 47, Issue:26
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
AID282099Reduction of viral protein in Huh7 cells containing HCV sub-genomic replicon after 3 days2004Journal of medicinal chemistry, Dec-16, Volume: 47, Issue:26
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
AID479458Apparent permeability from basolateral to apical side of human Caco-2 cells2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
AID479455Antiviral activity against HCV 1b BB7 infected in human HuH7 cells assessed as total viral RNA level after 3 days by RT-PCR analysis2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
AID282087Inhibition of HCV NS5B polymerase2004Journal of medicinal chemistry, Dec-16, Volume: 47, Issue:26
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
AID580563Antiviral activity against Hepatitis C virus genotype 1b Con1 infected in human HuH7 cells assessed as GAPDH RNA or 18S rRNA level after 3 days by qRT-PCR analysis2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).
AID392510Antiviral activity against Hepatitis C virus2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
AID282096Reduction of viral RNA in Huh7 cells containing HCV sub-genomic replicon after 3 days2004Journal of medicinal chemistry, Dec-16, Volume: 47, Issue:26
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
AID479459Ratio of apparent permeability from apical to basolateral side over basolateral to apical side in human Caco-2 cells2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
AID282097Inhibition of human mitochondrial DNA polymerase gamma up to 80 uM2004Journal of medicinal chemistry, Dec-16, Volume: 47, Issue:26
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
AID580560Antiviral activity against Hepatitis C virus genotype 1b Con1 infected in human HuH7 cells assessed as GAPDH RNA or 18S rRNA level after 3 days selected with 40 nM HCV-796 and 800 nM boceprevir by qRT-PCR analysis relative to control2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).
AID282093Inhibition of HCV 1a NS5B polymerase2004Journal of medicinal chemistry, Dec-16, Volume: 47, Issue:26
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
AID1070897Cytotoxicity against human MT4 cells after 5 days by Cell Titre Glo assay2014Journal of medicinal chemistry, Mar-13, Volume: 57, Issue:5
Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infection.
AID479460Cytotoxicity against human HuH7 cells assessed as BrdU incorporation in to cellular DNA by counter assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
AID282095Inhibition of HCV 3a NS5B polymerase2004Journal of medicinal chemistry, Dec-16, Volume: 47, Issue:26
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
AID597867Inhibition of HCV BK NS5B polymerase after 15 mins2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
AID479454Antiviral activity against HCV 1b BB7 infected in human HuH7 cells after 3 days by ELISA2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
AID282094Inhibition of HCV 1b NS5B polymerase2004Journal of medicinal chemistry, Dec-16, Volume: 47, Issue:26
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
AID479456Antiviral activity against HCV 1b BB7 infected in human HuH7 cells assessed as GAPDH RNA level after 3 days by RT-PCR analysis2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
AID580561Antiviral activity against Hepatitis C virus genotype 1b Con1 infected in human HuH7 cells assessed as GAPDH RNA or 18S rRNA level after 3 days selected with 40 nM HCV-796 and 800 nM boceprevir by qRT-PCR analysis2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).
AID597869Antiviral activity against HCV genotype 1b infected in human Huh7 cells assessed as decrease in viral NS5A levels after 3 days by ELISA2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
AID479453Inhibition of HCV 1b BB7 NS5B Cdelta21 polymerase expressed in Escherichia coli after 120 mins2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]